Skip to content

Clinical trials

Phase 3 Lymphoma, B-Cell, Marginal Zone trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Phase: Phase 3 Country / region: United States Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20023
20042
20051
20062
20073
20084
20132
20142
20151
20171
20191
20212
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated6
Active, not recruiting3
Recruiting2
Unknown status2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center5
Fred Hutchinson Cancer Center3
Gilead Sciences3
Alliance for Clinical Trials in Oncology2
Jonsson Comprehensive Cancer Center2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2
Vanderbilt-Ingram Cancer Center2
Baxalta now part of Shire1
BeOne Medicines1
CTI BioPharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone41
Lymphoma, Follicular39
Leukemia, Lymphocytic, Chronic, B-Cell33
Lymphoma, Non-Hodgkin29
Lymphoma, Mantle-Cell28
Lymphoma, Large B-Cell, Diffuse27
Lymphoma, Large-Cell, Immunoblastic26
Burkitt Lymphoma25
Precursor Cell Lymphoblastic Leukemia-Lymphoma25
Hodgkin Disease24

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.